InvestorsHub Logo
Followers 230
Posts 21490
Boards Moderated 2
Alias Born 08/03/2006

Re: TruckingAngler post# 9393

Tuesday, 01/04/2022 8:21:56 AM

Tuesday, January 04, 2022 8:21:56 AM

Post# of 9772
Giddy up!! $SNGX Dusquetide previously demonstrated benefits in reducing the duration of severe oral mucositis (SOM) in a Phase 2 clinical trial and reduction in SOM rates in the per protocol population in a Phase 3 study. In addition to the reduction of severe oral mucositis, an acceleration in the clearance of tumor response and an increase in overall survival were also observed in the Phase 2 clinical study as an ancillary benefit to treating oral mucositis in patients receiving chemo-radiation for their head and neck cancer (HNC).


https://finance.yahoo.com/news/dusquetide-demonstrates-positive-anti-tumor-123000840.html


Do your research! Play the TA. All posts are my opinion.
Is fundamental trading dead?

"We hope not." Richard Dennis

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNGX News